DCLK1 and pancreatic ductal adenocarcinoma: The selective compound DCLK1-IN-1 helped to establish cell motility as a role of DCLK1 in patient-derived pancreatic ductal carcinoma organoids and differentiate results obtained with earlier and less selective probes (53, 54).